Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration

Annual Review of Neuroscience

Volumn 24, Issue , 2001, Pages 239-262

  Musunuru, K ^a   Darnell, R B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Autoimmune disease; Neuron specific proteins; Neuronal survival; Onconeural antigens; Tumor immunity

Indexed keywords

ANTIGEN; NERVE PROTEIN; ONCOPROTEIN; RECOVERIN; RHODOPSIN; RNA BINDING PROTEIN;

AUTOIMMUNE DISEASE; ENCEPHALOMYELITIS; HUMAN; NERVE CELL DEGENERATION; NEUROBIOLOGY; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENSORY NEUROPATHY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR IMMUNOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; NEOPLASMS; NERVE DEGENERATION; PARANEOPLASTIC POLYNEUROPATHY; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 0034922092     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.24.1.239     Document Type: Review

References (142)

1. Role of anti-recoverin autoantibodies in cancer-associated retinopathy
2. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo
3. Recoverin: A potent uveitogen for the induction of photoreceptor degeneration in Lewis rats
4. Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems
5. Broken dogma: Penetration of autoantibodies into living cells
6. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration
7. Tumor-specific killer cells in paraneoplastic cerebellar degeneration
8. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
9. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
10. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer
11. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: A distinct paraneoplastic syndrome
12. Autoimmune pathogenesis of paraneoplastic neurological syndromes
13. Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and post-transcriptional gene expression
14. Messenger ribonucleoprotein complexes containing human ELAV proteins: Interactions with cytoskeleton and translational apparatus
15. ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells
16. ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is up-regulated during serum stimulation and T cell activation
17. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: A correlation of HuD messenger RNA levels with favorable prognostic features
18. Dendritic cells and the control of immunity
19. Brain-immune connection: Immuno-regulatory properties of CNS-resident cells
20. Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons
21. An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma
22. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo
23. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system
24. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies
25. An antineuronal autoantibody in paraneoplastic opsoclonus
26. Conserved structures and diversity of functions of RNA-binding proteins
27. The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream
28. A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues
29. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity
30. Interactions between lymphocytes, macrophages, and central nervous system cells
31. Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration
32. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues
33. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - A quantitative Western blot analysis
34. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuropathy: A clinical study of 71 patients
35. Mal, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders
36. Paraneoplastic syndromes
37. Cdr2, a target antigen of naturally occurring tumor immunity, is widely expressed in gynecologic tumors
38. Onconeural antigens and the paraneoplastic neurologic disorders: At the intersection of cancer, immunity and the brain
39. Immunologic complexity in neurons
40. The importance of defining the paraneoplastic neurologic disorders
41. Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors
42. Opsoclonus in adults: Report of three cases and review of the literature
43. 2+-dependent membrane interaction
44. Recoverin: A calcium sensitive activator of retinal rod guanylate cyclase
45. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration
46. A matter of life and cell death
47. HNS, a nuclearcytoplasmic shuttling sequence in HuR
48. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs
49. Cloning of a leucinezipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration
50. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice
51. Protein size and cerebrospinal fluid composition
52. Internalization of plasma proteins by cerebellar Purkinje cells
53. Penetration and internalization of plasma proteins in the human spinal cord
54. Three-dimensional structure of recoverin, a calcium sensor in vision
55. Endocytosis proteins and cancer: A potential link?
56. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA dead-enylation/degradation system
57. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration
58. HuR binding to cytoplasmic mRNA is perturbed by heat shock
59. Selection of a subset of mRNAs from combinatorial 3′ untranslated region libraries using neuronal RNA-binding protein Hel-N1
60. + mRNA in granular RNP structures and are implicated in neuronal differentiation
61. Recoverin is highly uveitogenic in Lewis rats
62. Recoverin mediates the calcium effect upon rhodopsin phosphorylation and cGMP hydrolysis in bovine retina rod cells
63. Splicing regulation in neurons: Tinkering with cell-specific control
64. Genetic evidence for a Nova regulator of alternative splicing in the brain
65. Anti-Hu antibodies in patients with small-cell lung cancer: Association with complete response to therapy and improved survival
66. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease
67. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model
68. The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons
69. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma
70. Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro
71. Mechanisms of complex transcriptional regulation: Implications for brain development
72. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
73. Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration
74. RNA editing of AMPA receptor subunit GluR-B: A base-paired intron-exon structure determines position and efficiency
75. Cell-specific translational control of transcription factor BTEB expression
76. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
77. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells
78. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen
79. Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GluT1) expression in 3T3-L1 adipocytes
80. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability
81. The tetranucleotide UCAY directs the specific recognition of RNA by the Nova KH3 domain
82. Rhodopsin phosphorylation as a mechanism of cyclic GMP phosphodiesterase regulation by S-modulin
83. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets
84. Photoreceptor degeneration. Possible autoimmune disorder
85. ELAV, a Drosophila neuron-specific protein, mediates the generation of an alternatively spliced neural protein isoform
86. The neuron-enriched splicing pattern of Drosophila erect wing is dependent on the presence of ELAV protein
87. Retinal degeneration is rescued in transgenic rd mice by expression of the cGMP phosphodiesterase β subunit
88. Hel-N1: An autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factor mRNA's
89. Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains
90. Sequence-specific RNA binding by a Nova KH domain: Implications for paraneoplastic disease and the fragile X syndrome
91. Regulation of alternative 3′ splice site selection by constitutive splicing factors
92. An intron enhancer recognized by splicing factors activates polyadenylation
93. Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancer
94. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein
95. Hu antigens: Reactivity with Hu antibodies, tumor expression, and major immunogenic sites
96. c-src contains a six-amino acid insertion relative to its non-neuronal counterpart
97. Expression of a photoreceptor protein, recoverin, as a cancer-associated retinopathy autoantigen in human lung cancer cell lines
98. The role of calcium-binding sites in S-modulin function
99. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations
100. Photoreceptor membrane proteins, phototransduction, and retinal degenerative diseases. The Friedenwald Lecture
101. Three-dimensional structure and stability of the KH domain: Molecular insights into the fragile X syndrome
102. Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay
103. Induction of MHC class I genes in neurons
104. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: Differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha
105. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo
106. A hierarchy of Hu RNA binding proteins in developing and adult neurons
107. The cytoplasmic Purkinje antigen cdr2 downregulates Myc function: Implications for neuronal and tumor cell survival
108. Transgenic mice with a rhodopsin mutation (Pro23His): A mouse model of autosomal dominant retinitis pigmentosa
109. Eukaryotic transcription factor-DNA complexes
110. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein
111. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients
112. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy
113. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy
114. A brain-enriched polypyrimidine tract-binding protein antagonizes the ability of Nova to regulate neuron-specific alternative splicing
115. Paraneoplastic syndromes
116. The neurobiology of the opsoclonus-myoclonus syndrome
117. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
118. Messenger RNA degradation in eukaryotes
119. A hippocampal protein associated with paraneoplastic neurologic syndrome and small cell lung carcinoma
120. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal antibody from a patient with paraneoplastic cerebellar degeneration
121. Analysis of autoantibody binding to 52-kd paraneoplastic cerebellar degeneration-associated antigen expressed in recombinant proteins
122. Blindness caused by photoreceptor degeneration as a remote effect of cancer
123. RNA editing
124. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins
125. Photoreceptor deactivation and retinal degeneration mediated by a photoreceptor-specific protein kinase C
126. Clathrin light chain B: Gene structure and neuron-specific splicing
127. A sequence compilation and comparison of exons that are alternatively spliced in neurons
128. Getting the message from the gene to the synapse: Sorting and intracellular transport of RNA in neurons
129. Proteins binding to 5′ untranslated region sites: A general mechanism for translation regulation of mRNAs in human and yeast cells
130. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav Sex-lethal
131. Autoantibodies in pathology and cell biology
132. The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells
133. Cancer-associated retinopathy
134. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retina, optic-nerve and cancer cells
135. The cancer-associated retinopathy antigen is a recoverin-like protein
136. Posttranscriptional regulation: The dawn of PTB
137. Sequential expression and role of Hu RNA-binding proteins during neurogenesis
138. Autoimmunity and neurological disease: Antibody modulation of synaptic transmission
139. Traffic of hematogenous cells through the central nervous system
140. The neuronal RNA binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia
141. Calcium-myristoyl protein switch